drugset / Trial / NCT01030640
Study To Assess Changes In The Number Of Nerves In The Skin At The Site Where Where Tanezumab Is Injected
Non-randomizedParallel-groupDouble-blindTreatment
Summary
Subcutaneous administration of tanezumab can result in changes in the number of nerves around the injection site in the thigh.
Timeline
- Start
- 2009-12
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tanezumab | Monoclonal antibody | 20 mg | Subcutaneous |